Wen-jing Zhu,1,* Shu-di Yang,1,* Chen-xi Qu,1 Qiao-ling Zhu,1,2 Wei-liang Chen,1 Fang Li,1 Zhi-qiang Yuan,1 Yang Liu,1 Ben-gang You,1 Xue-nong Zhang1 1Department of Pharmaceutics, College of Pharmaceutical Sciences, Soochow University, Suzhou, 2Department of Clinical Medicine, Nanjing Gulou Hospital, Nanjing, People’s Republic of China *These authors contributed equally to this work Abstract: Multidrug resistance (MDR) is a major obstacle for the clinical therapy of malignant human cancers. The discovery of RNA interference provides efficient gene silencing within tumor cells for reversing MDR. In this study, a new “binary polymer” low-density lipoprotein–N-succinyl chitosan–cystamine–urocanic acid (LD...
The combination of chemotherapy and RNA interference is a promising approach for efficient cancer th...
Mingji Jin,1,2,* Yan Hou,1– 3,* Xiuquan Quan,1,2,4,* Liqing Chen,1,2 Zhonggao Gao,1,2 We...
Wei Gao,1 Guihua Ye,1 Xiaochuan Duan,1 Xiaoying Yang,1 Victor C Yang1,2 1Tianjin Key Laboratory on ...
Jun Li,1,* Ruitong Xu,2,* Xiao Lu,3 Jing He,1 Shidai Jin1 1Department of Medical Oncology, 2Departm...
Qiang Huo,1,* Jianhua Zhu,1,2,* Yimin Niu,3 Huihui Shi,2 Yaxiang Gong,2 Yang Li,2 Huihui Song,4 Yang...
To concurrently suppress multidrug resistance (MDR) and metastasis of breast cancer cells, paclitaxe...
Yanqiu Zhang,1,2,* Lianjun Peng,3,* Jiahui Chu,4 Ming Zhang,5 Lizhu Sun,1,2 Bin Zhong,5 Qiyong Wu5 ...
To evaluate novel mixed polymeric micelles based on monomethoxy poly(ethylene glycol)-poly(D,L-lacti...
International audienceThe discovery that survivin, a small anti-apoptotic protein, is involved in ch...
International audienceThe discovery that survivin, a small anti-apoptotic protein, is involved in ch...
Jing Lin,* Chaoyue Zhao,* Cuijuan Liu, Shiyao Fu, Luying Han, Xinping Lu, Chunrong Yang College of ...
Ovarian cancer is a dreadful disease estimated to be the second most common gynecologic malignancy w...
Although many carriers for the delivery of chemotherapeutic drugs have been investigated, the disadv...
Ovarian cancer is a dreadful disease estimated to be the second most common gynecologic malignancy w...
The discovery that survivin, a small anti-apoptotic protein, is involved in chemoresistance, opens a...
The combination of chemotherapy and RNA interference is a promising approach for efficient cancer th...
Mingji Jin,1,2,* Yan Hou,1– 3,* Xiuquan Quan,1,2,4,* Liqing Chen,1,2 Zhonggao Gao,1,2 We...
Wei Gao,1 Guihua Ye,1 Xiaochuan Duan,1 Xiaoying Yang,1 Victor C Yang1,2 1Tianjin Key Laboratory on ...
Jun Li,1,* Ruitong Xu,2,* Xiao Lu,3 Jing He,1 Shidai Jin1 1Department of Medical Oncology, 2Departm...
Qiang Huo,1,* Jianhua Zhu,1,2,* Yimin Niu,3 Huihui Shi,2 Yaxiang Gong,2 Yang Li,2 Huihui Song,4 Yang...
To concurrently suppress multidrug resistance (MDR) and metastasis of breast cancer cells, paclitaxe...
Yanqiu Zhang,1,2,* Lianjun Peng,3,* Jiahui Chu,4 Ming Zhang,5 Lizhu Sun,1,2 Bin Zhong,5 Qiyong Wu5 ...
To evaluate novel mixed polymeric micelles based on monomethoxy poly(ethylene glycol)-poly(D,L-lacti...
International audienceThe discovery that survivin, a small anti-apoptotic protein, is involved in ch...
International audienceThe discovery that survivin, a small anti-apoptotic protein, is involved in ch...
Jing Lin,* Chaoyue Zhao,* Cuijuan Liu, Shiyao Fu, Luying Han, Xinping Lu, Chunrong Yang College of ...
Ovarian cancer is a dreadful disease estimated to be the second most common gynecologic malignancy w...
Although many carriers for the delivery of chemotherapeutic drugs have been investigated, the disadv...
Ovarian cancer is a dreadful disease estimated to be the second most common gynecologic malignancy w...
The discovery that survivin, a small anti-apoptotic protein, is involved in chemoresistance, opens a...
The combination of chemotherapy and RNA interference is a promising approach for efficient cancer th...
Mingji Jin,1,2,* Yan Hou,1– 3,* Xiuquan Quan,1,2,4,* Liqing Chen,1,2 Zhonggao Gao,1,2 We...
Wei Gao,1 Guihua Ye,1 Xiaochuan Duan,1 Xiaoying Yang,1 Victor C Yang1,2 1Tianjin Key Laboratory on ...